Molecular STEP 1 USMLE (Biochemistry)
Created by Franyelis Frias
| Term | Definition |
|---|---|
Inactive, more dense (darkly) and formed by methylation histones. | Heterochromatin
|
A mutation in this promoter prevents the binding of GENERAL TRANSCRIPTION FACTORS | TATA box |
Only this structure has its own DNA without Histones in its structure. | Mitochondria |
Its DNA is code for components of the electron transport chain. | Mitochondria |
Chromatin Region that it's active, less dense, can be transcriptional and its formed by acetylation of histones. | Euchromatin |
Structure of the chromatin that has the appearance of "beads on a string". | Histones |
Protein that links the DNA to the histones. | H1 protein |
Bind enhancer to promote transcription and can be upstream or downstream | Activators |
Binds silencers to decrease transcription. | Repressor |
5-Fluorouracil îs a drug used in chemotherapy, produce severe gastrointestinal symptoms and inhibits the metabolic pathway of... | Pyrimidine |
Allopurinol used for Systemic lupus erythematosus inhibits the enzyme: | Xantine Oxidase |
Azathioprine is a prodrug that produce 6-mecaptopurine who inhibits the pathway... | novo purine synthesis |
When you use Allopurinol and Azathioprine you produce bone marrow suppression that it's causes for an accumulation of... | 6-mercaptopurine
|
Development delay, self-mutilation (hand/lio biting or smashing), orange urine crystals, hiperuricemia and there are a deficiency of guanine and GMP | Lesch Nyhan Syndrome |
The Lesch Nyhan Syndrome is caused by a | HGPRT deficiency |
Becomes the guanine in GMP (nucleotide) | HGPRT |
The guanine that accumulates when there is HGPRT deficiency become in: | xanthine (uric acid) |
Drugs used for Lesch Nyhan syndrome | Allopurinol and Febuxostat (inhibits xantina oxidase) |
Bases substitution that results in a early stop, usually are | UAA, UAG, UGA "(AA, AG, GA) GAGA" to remember |
Hypotonia, feeding difficulties with a mutation in the SMN1 (deletion of a single nucleotide) | Duchenne muscular dystrophic |
When a nucleotide is missing or added (deletion or insertion) and it is no divisible by 3 there is a: | Frameshift mutation (truncated non-functional protein) |
Grown delay and unusual face and a mutation that disrupts the removal of introns | Marfan syndrome |
Mutation than disrupts the removal of introns and retain it in mRNA. | Slice site mutation |
Desease causes by a mutation that affects the mismatch repair | Lynch syndrome (HNPCC)
|
Photosensitivity, dry skin, multiple skin cancer and dymeres of pyrimidines | Xeroderma pigmentosum |
In Xeroderma pigmentosum which mechanism is affect | Nucleotide excision repair (endonuclease remove the oligoneuclotides) |